Tizanidine
- Product NDC
- 50090-6757
- 11-digit product format
- 500906757
- Labeler code
- 50090
- Product ID
- 50090-6757_79fb9e47-ef5b-41ac-935f-cc87a3e5d525
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA076286
- Marketing category
- ANDA
- Marketing start
- 2021-06-15
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| B53E3NMY5C | TIZANIDINE HYDROCHLORIDE | 64461-82-1 | TIZANIDINE HYDROCHLORIDE |
| 6AI06C00GW | TIZANIDINE | 51322-75-9 | Tizanidine |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6757-0 | 50090675700 | 90 TABLET in 1 BOTTLE (50090-6757-0) | 90 tablet | 2023-10-17 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Tizanidine | A-S Medication Solutions | 2023-10-18 | HUMAN PRESCRIPTION DRUG LABEL | 1 |